Nanjing Pharmaceutical Co., Ltd., referred to as Nanjing Pharmaceutical for short, is the major shareholder of Nanjing Xingong Investment Group Co., Ltd., with a shareholding ratio of 44. 1273%. It is a cross-regional and networked group enterprise, and the actual controller is the State-owned Assets Supervision and Administration Commission of Nanjing Municipal People's Government.
Since its establishment, Nanjing Medicine has been focusing on the development of big health industry, and its main business includes pharmaceutical wholesale and retail. Its market network covers Jiangsu, Anhui, Hubei, Fujian and other places, as well as Kunming in southwest China, and its business covers nearly 70 cities. It has accumulated rich medical management experience, resources and extensive brand awareness in the regional market, and has become one of the main enterprises in Nanjing's new medicine, life and health industrial chain, and also a demonstration enterprise in Nanjing's modern medicine supply chain system project.
At present, Nanjing Medicine has won an award? National pharmaceutical circulation innovation demonstration enterprise? The honor was won by the first batch? National demonstration enterprise of supply chain innovation and application? One of the enterprises with this title has the highest market share in Jiangsu, Anhui, Hubei and Fujian provinces. In addition, the company's annual operating income is more than 50 billion yuan, and its total assets are more than 33 billion yuan, ranking sixth in the scale of domestic pharmaceutical circulation industry, and ranking 257th among China's Fortune 500 listed companies in 2023.
If you need to know more about Nanjing Pharmaceutical Co., Ltd., I suggest you go to the enterprise to find out-check the enterprise for free.